ATE146528T1 - Kleinzelliger lungenkarzinom-spezifischer antikörper und antigenen - Google Patents

Kleinzelliger lungenkarzinom-spezifischer antikörper und antigenen

Info

Publication number
ATE146528T1
ATE146528T1 AT93917710T AT93917710T ATE146528T1 AT E146528 T1 ATE146528 T1 AT E146528T1 AT 93917710 T AT93917710 T AT 93917710T AT 93917710 T AT93917710 T AT 93917710T AT E146528 T1 ATE146528 T1 AT E146528T1
Authority
AT
Austria
Prior art keywords
pct
lung
small
cell carcinoma
antigen
Prior art date
Application number
AT93917710T
Other languages
English (en)
Inventor
Rolf Stahel
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of ATE146528T1 publication Critical patent/ATE146528T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93917710T 1992-09-17 1993-07-30 Kleinzelliger lungenkarzinom-spezifischer antikörper und antigenen ATE146528T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4231066 1992-09-17
DE4314870 1993-05-05

Publications (1)

Publication Number Publication Date
ATE146528T1 true ATE146528T1 (de) 1997-01-15

Family

ID=25918595

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93917710T ATE146528T1 (de) 1992-09-17 1993-07-30 Kleinzelliger lungenkarzinom-spezifischer antikörper und antigenen

Country Status (7)

Country Link
US (1) US5614373A (de)
EP (1) EP0662147B1 (de)
AT (1) ATE146528T1 (de)
AU (1) AU683845B2 (de)
CA (1) CA2144750A1 (de)
DE (1) DE69306803T2 (de)
WO (1) WO1994006929A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207805B1 (en) 1997-07-18 2001-03-27 University Of Iowa Research Foundation Prostate cell surface antigen-specific antibodies
US6737514B1 (en) 1998-12-22 2004-05-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6531315B1 (en) 1998-03-18 2003-03-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6518256B1 (en) 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6482597B1 (en) 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6312695B1 (en) 1998-03-18 2001-11-06 Corixa Corporation Compounds and methods for therapy of lung cancer
US6426072B1 (en) 2000-08-02 2002-07-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US6821518B1 (en) 1998-03-18 2004-11-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6660838B1 (en) 1998-03-18 2003-12-09 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
EA005140B1 (ru) * 1999-04-02 2004-12-30 Корикса Корпорейшн Соединения и способы для лечения и диагностики рака легкого
CA2427643C (en) * 2000-11-02 2014-04-15 Molecular Discoveries, L.L.C. Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
US6894149B2 (en) * 2001-10-11 2005-05-17 Protein Design Labs, Inc. Anti-HLA-DA antibodies and the methods of using thereof
JP4212921B2 (ja) * 2002-03-29 2009-01-21 独立行政法人科学技術振興機構 抗体を提示するタンパク質中空ナノ粒子を用いる治療薬剤およびタンパク質中空ナノ粒子
GB0803192D0 (en) * 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
EP2737317A2 (de) 2011-07-28 2014-06-04 The Trustees Of The University Of Pennsylvania Verfahren zur krebsdiagnose durch tumorzellencharakterisierung mithilfe pleuraler oder seröser flüssigkeiten
WO2014052876A1 (en) * 2012-09-28 2014-04-03 Immunogen Inc. Methods for increasing efficacy of cd56- based therapy
WO2017184534A1 (en) * 2016-04-18 2017-10-26 The Gorlin Companies Methods and compositions for improving safety and efficacy of natural killer cell immunotherapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323802A3 (de) * 1987-12-24 1989-07-26 Sandoz Ag Gegen Lungenkrebs gerichtete monoklonale Antikörper und Zelloberflächenantigen davon
GB8820036D0 (en) * 1988-08-24 1988-09-28 Sandoz Ltd Monoclonal antibodies
DE4005630A1 (de) * 1990-02-22 1991-09-05 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte antigene, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
DE69306803T2 (de) 1997-05-15
AU4705293A (en) 1994-04-12
AU683845B2 (en) 1997-11-27
US5614373A (en) 1997-03-25
EP0662147B1 (de) 1996-12-18
EP0662147A1 (de) 1995-07-12
WO1994006929A1 (en) 1994-03-31
CA2144750A1 (en) 1994-03-31
DE69306803D1 (de) 1997-01-30

Similar Documents

Publication Publication Date Title
ATE146528T1 (de) Kleinzelliger lungenkarzinom-spezifischer antikörper und antigenen
AU661816B2 (en) Urinary tumor associated antigen, antigenic subunits uses and methods of detection
IL126314A0 (en) Monoclonal specific antibodies
ATE101202T1 (de) Antikoerper.
EP0420913A4 (en) Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
DE69129989D1 (de) Arzneimittelzusammensetzung zur behandlung oder vorbeugung maligner tumore
CA2451680A1 (en) Human dr4 antibodies and uses thereof
FI964845A0 (fi) CD44v6:n vastaiset monoklonaaliset vasta-aineet
IL148113A0 (en) Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
EP0352722A3 (de) Bindungstests für Adenocarcinoma-Antigen und Reagenzien
ITRM920457A1 (it) Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.
ATE248189T1 (de) Antikörper gegen vasp (vasodilator-stimulated phosphoprotein), hybridomzellen für deren gewinnung, und deren verwendung
Olsen et al. Unique antigenic determinants (idiotypes) used as markers in a patient with macroglobulinemia and urticaria: similar idiotypes demonstrated in the skin and on peripheral blood lymphocytes
ATE77243T1 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
US7097846B2 (en) 35 kD tumor associated protein antigen: uses and methods of detection
Kakiuchi et al. Preparation and effects of an anti-B cell serum
Gallagher et al. Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapy
Partridge et al. Subclasses of IgG on the surface of human lymphocytes: a study with monoclonal antibodies
Poston et al. Specific enzyme treatment is required for individual monoclonal antibodies in immunohistochemistry with formalin fixed sections
Heyman et al. Primary and secondary IgG are equally efficient immunosuppressors in relation to antigen binding capacity
Arlen et al. Monoclonal antibodies and their role in modulation of the immune response
Eskinazi et al. Monoclonal antibodies against squamous cell carcinoma
Moav et al. Anti-Trichomonas vaginalis monoclonal antibodies inducing complement-dependent cytotoxicity
JONES CHARACTERIZATION OF A CONSERVED SURFACE PROTEIN OF NEISSERIA GONORRHOEAE WITH IDIOTYPIC AND ANTI-IDIOTYPIC ANTIBODIES
Suzuki et al. Detection of antigen-specific suppressor T cell factor by sandwich radioimmunoassay using two monoclonal antibodies with different specificities

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee